Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 17861 - 17880 out of 554124 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FG01) bevacizumab | Vegzelma 400 mg/16 mL injection, 16 mL vial | Solution for I.V. infusion 400 mg in 16 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FX02) gemtuzumab ozogamicin | Mylotarg 5 mg powder for injection, 1 vial | Powder for injection 5 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerAustraliaPtyLtd |
| Australia | (L01FX02) gemtuzumab ozogamicin | Mylotarg 5 mg powder for injection, 1 vial | Powder for injection 5 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerAustraliaPtyLtd |
| Australia | (L01FX04) ipilimumab (adm: P) | Yervoy 200 mg/40 mL injection, 40 mL vial | Injection concentrate for I.V. infusion 200 mg in 40 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX04) ipilimumab (adm: P) | Yervoy 200 mg/40 mL injection, 40 mL vial | Injection concentrate for I.V. infusion 200 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX04) ipilimumab (adm: P) | Yervoy 50 mg/10 mL injection, 10 mL vial | Injection concentrate for I.V. infusion 50 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX04) ipilimumab (adm: P) | Yervoy 50 mg/10 mL injection, 10 mL vial | Injection concentrate for I.V. infusion 50 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX07) blinatumomab (adm: P) | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab (adm: P) | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
Pages
